Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

BACKGROUND: In the era of personalized medicine, the establishment of preclinical models of cancer that faithfully recapitulate original tumors is essential to potentially guide clinical decisions. METHODS: We established 7 models [4 cell lines, 2 Patient-Derived Tumor Organoids (PDTO) and 1 Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorel, Lucie, Morice, Pierre-Marie, Paysant, Hippolyte, Florent, Romane, Babin, Guillaume, Thomine, Cécilia, Perréard, Marion, Abeilard, Edwige, Giffard, Florence, Brotin, Emilie, Denoyelle, Christophe, Villenet, Céline, Sebda, Shéhérazade, Briand, Mélanie, Joly, Florence, Dolivet, Enora, Goux, Didier, Blanc-Fournier, Cécile, Jeanne, Corinne, Villedieu, Marie, Meryet-Figuiere, Matthieu, Figeac, Martin, Poulain, Laurent, Weiswald, Louis-Bastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559504/
https://www.ncbi.nlm.nih.gov/pubmed/37803448
http://dx.doi.org/10.1186/s13046-023-02809-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559504/
https://www.ncbi.nlm.nih.gov/pubmed/37803448
http://dx.doi.org/10.1186/s13046-023-02809-8

Ejemplares similares